ArticleBritish journal of pharmacology2010

A novel antagonist of the prostaglandin E(2) EP(4) receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models.

Q Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.